Healwell AI's Global Expansion Strategy Gains Momentum with Key Middle East Contract

Healwell AI's acquisition of Orion Health yields first Middle East contract, driving international revenue and product growth across North America.

Healwell AI Inc. is demonstrating the tangible benefits of its strategic growth plan. The Canadian artificial intelligence company recently secured its inaugural contract in the Middle East, marking a significant validation of its international expansion efforts. This development signals that the company's technology, already established in North America, is now generating concrete revenue in new global markets following its pivotal acquisition of Orion Health.

Strategic Acquisition Opens Doors to New Revenue

The cornerstone of Healwell's recent progress is its April 2025 acquisition of Orion Health. This move provided immediate access to Orion's established global network, a strategy that has now borne fruit. Last Thursday, Healwell AI announced a definitive agreement with a government-backed health system in the Middle East. Notably, this client was already part of the Orion Health network, illustrating how the acquisition is serving as a direct channel for deploying Healwell's proprietary AI solutions.

This contract underscores the scalability of the company's core DARWEN™ platform across diverse geographic regions. With this win, Healwell is now generating revenue in three key markets: Canada, the United States, and the Middle East. This international push coincides with a product rollout in North America, where the company is deploying solutions for patient identification and AI-powered search within various healthcare systems.

Product Innovation and Technological Consolidation

Alongside geographic growth, Healwell continues to advance its product suite. On February 19, the company, in partnership with WELL Health, launched the WELLTRUST platform. This privacy-compliant solution leverages AI to identify suitable patients for clinical trials.

The technological backbone for these applications remains the integrated DARWEN™ platform. A key operational milestone was reached in early 2026 when Healwell successfully completed the internal integration of its acquired Khure and Pentavere technologies into this central engine. This consolidation is designed to streamline both sales and operational efficiency. Investor sentiment has responded positively to this series of developments, with the company's shares posting a weekly gain exceeding 19 percent.

Financial Recovery and Upcoming Catalysts

The operational achievements are built upon a foundation of improving financial performance. Healwell had already reported record quarterly revenue of $30.4 million for Q3 2025. Furthermore, it achieved an adjusted EBITDA of $0.7 million, marking its second consecutive profitable quarter. The strategic vision behind the Orion Health acquisition—gaining access to a platform with over 150 million patient records globally—is beginning to materialize in the financial statements.

The management team is scheduled to present at several investor conferences in March to articulate this growth narrative. A significant near-term catalyst will occur on March 24, 2026, when Healwell releases its next quarterly earnings report. This update will provide critical evidence on whether the accelerated contract wins and Middle Eastern expansion are solidifying the positive trends in revenue and profitability.